Rheumatic Disease Patients with COVID-19: Is Timing Important for Biosimilars Therapy? Are Multiple Antiphospholipid Antibodies Associated with COVID-19? What Are the Downsides of Using Anti-Cytokine Therapy?

By RheumNow FEATURING John J. Cush
By RheumNow FEATURING John J. Cush
54 views
September 10, 2020
Comments 0
Login to view comments. Click here to Login